Abbisko Cayman Limited (HKG:2256)
Hong Kong
· Delayed Price · Currency is HKD 13.22
-0.39 (-2.87%)
Apr 29, 2026, 4:08 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 9.17 billion as of April 29, 2026. Its market cap has increased by 87.69% in one year.
Market Cap
9.17B
Enterprise Value
6.84B
Revenue
681.17M
Ranking
n/a
PE Ratio
138.29
Stock Price
13.22
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has increased from 8.71B to 9.17B, an increase of 5.24%. That is a compound annual growth rate of 1.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 8.90B | 1.80% |
| Dec 31, 2025 | 8.75B | 204.13% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Haohai Biological Technology | 9.38B |
| Lepu Biopharma | 9.74B |
| Alphamab Oncology | 10.59B |
| HBM Holdings | 10.97B |
| CARsgen Therapeutics Holdings | 11.74B |
| CK Life Sciences Int'l., (Holdings) | 7.02B |
| Guangzhou Innogen Pharmaceutical Group | 6.96B |
| Everest Medicines | 12.42B |